new indications for glp-1 drugs What to know about the era of What to Make of the
Description
In a similar study, patients with an A1C 7.5% reduced their insulin glargine dose by 30% when beginning tirzepatide

A traditional big-box PBM wouldnt do that

I know that fatjabs can cure anything, and the loss of lean mass is nothing to be worried about, the fact that when you stop it all reverses faster than ever before, AND longevity is associated with lean muscle NOT body fat

This supports weight management goals, but it also means many users eat significantly less food than before

Both peptides are chemically modified with lipid moieties to increase plasma protein binding and prolong systemic half-life, but tirzepatides dual-receptor activity results in broader metabolic signaling
